Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
Gallo A, Charriere S, Vimont A, Chapman MJ, Angoulvant D, Boccara F, Cariou B, Carreau V, Carrié A, Bruckert E, Béliard S; French REgistry of Familial hypERCHOLesterolemia (REFERCHOL) investigators. Gallo A, et al. Among authors: angoulvant d. Atherosclerosis. 2020 Aug;306:41-49. doi: 10.1016/j.atherosclerosis.2020.06.011. Epub 2020 Jul 6. Atherosclerosis. 2020. PMID: 32688103 Free article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood.
Mourre F, Giorgi R, Gallo A, Boccara F, Bruckert E, Carrié A, Hankard R, Inamo J, Laboureau S, Moulin P, Valéro R, Béliard S; REFERCHOL Investigators. Mourre F, et al. Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):e94-e103. doi: 10.1161/ATVBAHA.122.318119. Epub 2022 Dec 29. Arterioscler Thromb Vasc Biol. 2023. PMID: 36579650 Free article.
Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia.
Ferrières J, Farnier M, Bruckert E, Vimont A, Durlach V, Ferrari E, Gallo A, Boccara F, Ferrières D, Béliard S; French FH Registry group: French REgistry of Familial hypERCHOLesterolemia (REFERCHOL). Ferrières J, et al. Atheroscler Plus. 2022 Aug 17;50:17-24. doi: 10.1016/j.athplu.2022.08.001. eCollection 2022 Dec. Atheroscler Plus. 2022. PMID: 36643794 Free PMC article.
Rationale and design of the French cohort of acute myocarditis diagnosed by cardiac magnetic resonance imaging (MyocarditIRM).
Bouleti C, Servoz C, Alos B, Carsten E, Jacquier A, Ternacle J, Deux JF, Tea V, Mousseaux E, Garcia R, Bonnet G, Huttin O, Akodad M, Bejan-Angoulvant T, Lattuca B, Redheuil A, Glatt N, Angoulvant D, Ou P. Bouleti C, et al. Among authors: angoulvant d. Arch Cardiovasc Dis. 2024 May 8:S1875-2136(24)00071-8. doi: 10.1016/j.acvd.2024.04.002. Online ahead of print. Arch Cardiovasc Dis. 2024. PMID: 38797639
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators. Carson JL, et al. Am Heart J. 2023 Mar;257:120-129. doi: 10.1016/j.ahj.2022.11.015. Epub 2022 Nov 20. Am Heart J. 2023. PMID: 36417955 Free PMC article.
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study.
Maisons V, Halimi JM, Fauchier G, de Fréminville JB, Goin N, Gueguen J, Gatault P, Sautenet B, Angoulvant D, Herbert J, Bisson A, Ducluzeau PH, Fauchier L. Maisons V, et al. Among authors: angoulvant d. Diabetes Metab. 2023 May;49(3):101441. doi: 10.1016/j.diabet.2023.101441. Epub 2023 Mar 15. Diabetes Metab. 2023. PMID: 36931430
Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study.
Gautier A, Danchin N, Ducrocq G, Rousseau A, Cottin Y, Cayla G, Prunier F, Durand-Zaleski I, Ravaud P, Angoulvant D, Coste P, Lemesle G, Bouleti C, Popovic B, Ferrari E, Silvain J, Dubreuil O, Lhermusier T, Goube P, Schiele F, Vanzetto G, Aboyans V, Gallet R, Eltchaninoff H, Thuaire C, Dillinger JG, Paganelli F, Gourmelen J, Steg PG, Simon T; FRENCHIE investigators. Gautier A, et al. Among authors: angoulvant d. Arch Cardiovasc Dis. 2024 May 22:S1875-2136(24)00210-9. doi: 10.1016/j.acvd.2024.04.004. Online ahead of print. Arch Cardiovasc Dis. 2024. PMID: 38821761
225 results